RE: Takeda sales4 Aug 2024 17:20
Agreed, their note did read a little conservative in some areas although perhaps not a bad thing, 'under promise, over deliver' ?
Headline numbers for comparison look poor but that a given with the previous cash injection from Takeda agreement, underlying is looking strong with a slight road bump for SHPL post COVID sales.
They are still prioritising pipeline commercialisation over R & D which gave a corresponding drop in costs, not sure how this pans out into 2025 although J mentioned from the call these would increase somewhat.
We should start to see lower interest rates over the next few months which tends to favour growth stocks, long term hold for me.